Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So closing the offering early. Hiring the investor relations firm, using Twitter for further investor updates, completing a full audit Dating back 7 years, sending out actual DeltaWave masks to investors with sleep apnea to try, pink current, hiring empirical technologies with 100% success rate for 510 applications, responding back to FDA additional information request, moving from pre-revenue to revenue by signing a distribution deal to sell cpap machines….
I mean really do I have to go on…
Fine here I will do everything you posted that is “negative has occurred in 2020 or sooner… since December 15th the stock price is up over 1700%… I mean I’ve never seen somebody complain more then you when the company has put out nothing but gains for 16 months for its investors
My sentiments exactly:
Gonna be a fun month of June here IMO
Pumpers gaslighting folks that RMSL didn't fail when the toxicologist straight up says in the 8k that RMSL failed the cytotoxicity test, not just once but twice:
2022 PR: Whoops they forgot they failed a critical cytotoxicity test a year ago and are just now telling shareholders...but it was just "procedural"...wait...they also failed the retest.....
https://www.globenewswire.com/news-release/2022/03/28/2411010/0/en/RemSleep-Holdings-Inc-Provides-a-Shareholder-Update.html
2021 PR: Hired Empirical for "faster" clearance. Faster than 30 days? Wait...that was almost a year ago....
https://www.globenewswire.com/news-release/2021/06/02/2240023/0/en/REMSleep-510K.html
$RMSL FDA approval in 30 days or less. Load up.
https://www.otcmarkets.com/stock/RMSL/news/story?e&id=2207146
But Tom says this time is different!
2020 PR: Even though they had an old Twitter account giving updates on the 510k, they deleted it, claimed it was fake and started a new Twitter account:
https://www.globenewswire.com/news-release/2020/01/27/1975547/0/en/REMSleep-Holdings-Inc-Issues-Statement-Clarifying-Unauthorized-Twitter-Post-and-Account.html
2019 PR: They have made "steady progress" even though 2017 PR said they were ready for delivery:
https://www.globenewswire.com/news-release/2019/05/22/1841101/0/en/Remsleep-Holdings-Inc-Shareholder-Update.html
2018 PR says they are finalizing the DeltaWave even though the 2017 PR said they were ready for delivery:
https://www.globenewswire.com/news-release/2018/11/19/1654054/0/en/REMSleep-Holdings-Inc-Shareholder-Update.html
2017 PR touting DeltaWave pre-order delivering November2017:
https://www.biospace.com/article/releases/remsleep-holdings-launches-new-cpap-mask-designed-to-improve-sleep-apnea-patient-comfort-and-compliance-/
RMSL RemSleep Holdings Inc. Announces 510(k) Submission for DeltaWave
https://www.mcapmediawire.com/remsleep-holdings-inc-announces-510k-submission-for-deltawave/
Over SEVEN YEARS promising 510k....only a fool would believe 45 days for clearance.
Read their PR history and filings since 2015 to see the history of BS unfulfilled promises and completely inept management.
Howdy ihub. The next 6 months should be fun. Still holding. Generating sales revenue now, expecting FDA 510K to be resubmitted anytime. We expect FDA decision within 45 days of that. We should hear about the progress on uplisting, soonish. Setting new levels of support this month.
Finally breaking through .022 area resistance. Next area should be .026ish.
All OS shares are being accumulated in the .02 range. I would hold if I were you
Will be able to write this off against tax when they start making lots of money shortly
Current market cap is $30 million for a company that is $10 million in the hole.
Pressure is building ahead of a .022 long term trendline breakout. I think next week we see this make a major move up towards the .03 area.
Our first shipment of CPAP machines is expected to arrive at our Florida warehouse by approximately May 6th. A follow up order for an additional 2,000 machines will be expected to arrive in about 30 days. $RMSL
Do you mean going into fda submission of ai response? I would say this is going to see closer to $.05 pre official fda approval. Uplisting and cpap revenue are major catalysts
I think we see 0.024-0.027 going in to FDA approval.
Thank you, always trying to learn.
You know they are T trades when you see the "avg" listed under type. They are backend transactions that are usually posted after hours but sometimes post during trading hours.
Click Level 2 in the upper right corner from the RMSL message board and then click the Trades tab:
https://ih.advfn.com/stock-market/USOTC/remsleep-pk-RMSL/trades
Where do I find T trade information?
That’s true, however not for this stock.
Call the fire truck!This stock in on fire!
Diluting 200 million shares every quarter will get you to a maxed out A/S and reverse splitsville in no time.
Noteholders are making a killing. They probably converted their notes into shares somewhere between .001 and .005 and sold those converted shares at the T-trade avg of .0187. That was just a T-trade for one day. Great deal for the note sharks, not so great for shareholders buying in at .01 and .02 getting diluted to hell.
You can get a good idea of what rate they are converting their loans by looking at the notes to the financials. The 4Q financials show a $110k convertible note from the prior quarter converted 29,954,167 shares which is .00367 conversion rate.
The $205k convertible note that diluted 205 million shares equates to a .001 conversion rate.
That might suggest who ever is converting doesn't think the price is going to rise other wise $110,000 would be a pittance. Glad I'm playing with freebies, I am going to hold just in case.
Makes perfect sense. It's clear evidence of dilution which contradicts the pumpers telling folks that dilution is done because the "offering is closed".
CEO has plenty of cash from the offering to pay off the many convertible notes on the books to protect shareholders but he ADDED more convertible notes on the last financials.
The longer it takes (if ever) for the 510k clearance, the more cash they will burn through, more dilution and then the inevitable reverse split.
Makes no sense. How far is 110,000 going to take anyone?
Nice big a$$ double bottom in place here!We"re close folks.Standbye.
Pump "articles", Telegram rooms, and Kindergarten trading "Teams" create the necessary volume for the dump.
RMSL getting noticed. New article just out: https://microcapdaily.com/remsleep-holdings-inc-otcmkts-rmsl-getting-noticed-as-co-fills-orders-for-its-cpap-masks-and-looks-to-get-its-new-deltawave-cpap-approved/
The second lab is criticizing the hired toxicologist as much as they are criticizing the first lab because the toxicologist was hired to correct the procedures on the retest which ultimately failed on the retest.
The hired toxicologist set and/or reviewed the new protocol that failed:
He's also the one who chose the new lab before the first retested in case the new protocols didn't get the result they wanted.
Why would you need a backup lab if you were the one who revised the protocols that you claimed were erroneous in the first test that failed?
There are a lot of questions that need to be answered if they want to pass the scrutiny of the FDA who might perceive these actions as shopping for a specific result rather than looking out for the interest of public safety.
I do understand all the concerns due to past history though! GLTA
Saw that yesterday and thought it was very encouraging for this next round of testing. We shall see if the results are positive this next time.
"it is the opinion of the new lab
that the testing procedure was significantly erroneous and set up the REMSleep medical device for failure."
You missed this part....hmmm?
https://www.otcmarkets.com/filing/conv_pdf?id=15699670&guid=3A6wkanF-s5pQth
Followers
|
312
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
31338
|
Created
|
11/14/08
|
Type
|
Free
|
Moderators |
REMSleep Holdings, Inc. is engaged in the business of developing and distributing sleep apnea products. The Company focuses on offering optimum compliance and comfort for continuous positive airway pressure (CPAP) patients. Its DeltaWave CPAP interface (the DeltaWave) is a device to treat patients with sleep apnea. Its DeltaWave product is a nasal-pillows type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. Its target market includes home care dealers, private sleep labs, product end users, sleep physicians, medical groups, sleep product distributors, hospitals, medical associations, such as the American academy of sleep medicine and the American sleep association. REMSleep LLC is its wholly owned subsidiary.
INDUSTRY
Medical Equipment & Supplies
CONTACT INFO
2202 N. WEST SHORE BLVD SUITE 200
TAMPA, FL
33607
United States
+1.912.5902001
https://www.remsleep.com/EXECUTIVE LEADERSHIP
Russell Finlay Bird
Chairman of the Board
Thomas J. Wood
Chief Executive Officer, Director
Jonathan B Lane
Chief Technology Officer, Vice President
https://www.fundable.com/remsleep
Share Structure
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |